⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25172510 | 0.82 | — | — | |
| SCHEMBL310645 | 0.77 | — | — | |
| SCHEMBL15402844 | 0.74 | — | — | |
| SCHEMBL15404647 | 0.72 | — | — | |
| SCHEMBL29002153 | 0.72 | — | — | |
| SCHEMBL7408696 | 0.71 | — | — | |
| SCHEMBL627628 | 0.70 | — | — | |
| SCHEMBL6221673 | 0.69 | — | — | |
| SCHEMBL9045911 | 0.67 | — | — | |
| SCHEMBL22322333 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117888363-A | Washable shirt and production process thereof | 苍南县奇蒙服饰有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117888363-A | Washable shirt and production process thereof | 苍南县奇蒙服饰有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-112088160-B | 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives | UCB生物制药有限责任公司 | 2023-07-04 | — | — | CN | disclosed |
| EP-3921319-A1 | IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BeiGene, Ltd. (KY) | 2021-12-15 | — | — | EP | disclosed |
| WO-2020160710-A1 | IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEIGENE, LTD. (KY) | 2020-08-13 | — | — | WO | disclosed |
| EP-2491032-A1 | AKT INHIBITORS | Eli Lilly and Company (US) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011050016-A1 | AKT INHIBITORS | ELI LILLY AND COMPANY (US) | 2011-04-28 | — | — | WO | disclosed |